Loxo Oncology Inc (LOXO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD, CT 06901

Loxo Oncology Inc. researches and develops cancer drugs. The company focuses on building small molecule cancer drugs for genetically defined patient subsets.

Data as of 2019-02-21 02:29:24 -0500
Market Cap7.217 Billion Shares Outstanding30.755 Million Avg 30-day Volume
P/E Ratio Dividend Yield0.0 EPS-2.09
Price/Sales58.4363 Debt to Equity EBITDA0
Price to Book Value19.04 Forward PE Enterprise Value
Total Cash0 Current Debt Gross Profit0
BETA2.46431 52-week High/Low234.93 / 103.5 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from LOXO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LOXO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LOXO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLAHERTY KEITH T.

  • Director
0 2019-02-15 0

NAIDER AVI Z.

  • Director
0 2019-02-15 0

BILENKER JOSHUA H. PRESIDENT & CEO

  • Officer
  • Director
0 2019-02-15 0

ELMS STEVE

  • Director
  • 10% Owner
2,038,920 2019-02-15 0

KUNKEL LORI ANNE

  • Director
0 2019-02-15 0

FUHRMAN ALAN

  • Director
0 2019-02-15 0

BURSTEIN JENNIFER SENIOR VP OF FINANCE

  • Officer
0 2019-02-15 0

MAYLEBEN TIMOTHY M

  • Director
0 2019-02-15 0

VAN NAARDEN JACOB CHIEF OPERATING OFFICER

  • Officer
0 2019-02-15 0

HARR STEVE

  • Director
0 2019-02-15 0

NANDA NISHA CHIEF DEVELOPMENT OFFICER

  • Officer
0 2019-02-15 0

AISLING CAPITAL III LP

AISLING CAPITAL PARTNERS III LP

AISLING CAPITAL PARTNERS III LLC

ELMS STEVE

SCHIFF ANDREW N

PURCELL DENNIS J

  • 10% Owner
No longer subject to file 2018-07-10 0

BONITA DAVID P

  • Director
941,000 2017-12-08 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

ISALY SAMUEL D

  • Director
941,000 2017-12-08 0

BARRETT M JAMES

  • Director
  • 10% Owner
0 2015-07-28 0

GOLDSTEIN DOV A MD CFO AND TREASURER

  • Officer
  • 10% Owner
3,518,366 2015-04-01 0

LOW JENNIFER A. CHIEF MEDICAL OFFICER

  • Officer
0 2014-12-19 0

AISLING CAPITAL III LP

AISLING CAPITAL PARTNERS III LP

AISLING CAPITAL PARTNERS III LLC

ELMS STEVE

GOLDSTEIN DOV A MD CFO AND TREASURER

SCHIFF ANDREW N

PURCELL DENNIS J

  • Officer
  • Director
  • 10% Owner
3,452,493 2014-08-06 0

SONSINI PETER W.

  • 10% Owner
1,789,420 2014-08-06 0

WELLER HARRY R

  • 10% Owner
1,789,420 2014-08-06 0

VISWANATHAN RAVI

  • 10% Owner
1,789,420 2014-08-06 0

SANDELL SCOTT D

  • 10% Owner
1,789,420 2014-08-06 0

MOTT DAVID M

  • 10% Owner
1,789,420 2014-08-06 0

KOLLURI KRISHNA KITTU

  • 10% Owner
1,789,420 2014-08-06 0

KERINS PATRICK J

  • 10% Owner
1,789,420 2014-08-06 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
1,789,420 2014-08-06 0

DRANT RYAN D

  • 10% Owner
1,789,420 2014-08-06 0

BASKETT FOREST

  • 10% Owner
1,789,420 2014-08-06 0

BARRIS PETER J

  • 10% Owner
1,789,420 2014-08-06 0

AI LOXO HOLDINGS LLC

AI VALUE HOLDINGS, LLC

ACCESS INDUSTRIES MANAGEMENT, LLC

BLAVATNIK LEN

  • 10% Owner
1,368,339 2014-08-06 0

ARRAY BIOPHARMA INC

  • 10% Owner
1,609,560 2014-08-06 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
No longer subject to file 2014-08-06 0

MOYER MIKEL PAUL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-07-31 0

NEW ENTERPRISE ASSOCIATES 14, L.P.

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

  • 10% Owner
0 2014-07-31 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MANAGEMENT CO

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
0 2014-07-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments